N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143684 |
| CAS No | NA |
| Mol.F. | C22H29N3O6 |
| Mol.Wt. | 431.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143685 |
| CAS No | NA |
| Mol.F. | C24H33N3O6 |
| Mol.Wt. | 459.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143686 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143687 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143688 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143689 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143690 |
| CAS No | NA |
| Mol.F. | C15H18N2O3 : HCl |
| Mol.Wt. | 274.3 : 36.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143691 |
| CAS No | NA |
| Mol.F. | C12H13N3O4 |
| Mol.Wt. | 263.25 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143692 |
| CAS No | NA |
| Mol.F. | C7H9N5O |
| Mol.Wt. | 179.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143693 |
| CAS No | NA |
| Mol.F. | C19H15D4ClN4O7S |
| Mol.Wt. | 486.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143694 |
| CAS No | NA |
| Mol.F. | C21H26N4O3 |
| Mol.Wt. | 382.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143695 |
| CAS No | NA |
| Mol.F. | C12H9D3N2O |
| Mol.Wt. | 203.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143696 |
| CAS No | NA |
| Mol.F. | C15H23N5O3 |
| Mol.Wt. | 321.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143697 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143698 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143699 |
| CAS No | NA |
| Mol.F. | C10H14N6O2 |
| Mol.Wt. | 250.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |